Related Experiment Video
Updated: Jun 17, 2025

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
Published on: May 23, 2025
Catastrophic Antiphospholipid Syndrome: A Life-Threatening Condition
Sonal Prasad1, Jay Xiong1, Edsel Embry1
1Department of Internal Medicine, St. Joseph's Medical Center, Stockton, USA.
Catastrophic Antiphospholipid Syndrome (CAPS) is a rare, life-threatening condition causing multi-organ thrombosis. This case highlights the need for a multidisciplinary approach to diagnose and treat this complex disease effectively.
Area of Science:
- Rheumatology
- Hematology
- Critical Care Medicine
Background:
- Antiphospholipid syndrome (APS) involves thrombosis and antiphospholipid antibodies.
- Catastrophic APS (CAPS) is a severe, rare variant with high mortality.
- Standard CAPS treatment includes anticoagulation, glucocorticoids, and plasmapheresis or IVIG.
Observation:
- This report details a patient diagnosed with CAPS.
- The patient's condition necessitated complex management.
- A multidisciplinary team was crucial for patient care.
Findings:
- The case illustrates the challenges in diagnosing and managing CAPS.
- Effective treatment required a coordinated, team-based strategy.
- Prompt and comprehensive care is vital for improving outcomes.
Implications:
- This case underscores the importance of recognizing CAPS promptly.
- It emphasizes the critical role of multidisciplinary collaboration in managing rare, severe thrombotic disorders.
- Findings contribute to understanding optimal management strategies for CAPS patients.
More Related Videos
09:14Pre-Chiasmatic, Single Injection of Autologous Blood to Induce Experimental Subarachnoid Hemorrhage in a Rat Model
Published on: June 18, 2021
05:49Procoagulant Platelet Characterization by Measuring Phosphatidylserine Exposure and Microvesicle Release from Human Purified Platelets
Published on: November 29, 2024
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...